RxDoctor Payments Data

Kendra Ruckman, PA

Physician Assistant · Melbourne, FLNPI 1942523600

Payments from drug & device makers

$545in general payments, 2019–2025

Across 20 payments — averaging $27.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$117
  • Boston Scientific$113
  • Medtronic$71
  • Collegium Pharmaceutical, Inc.$57
  • MML US, Inc.$48
  • Vertex$40
  • plus $99 from 5 others

What the payments were for

  • Food & beverage$545100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$545 in reported general payments places this provider in the 50th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$17,739
Medicare patients
114
Services billed
363

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MovantikNaloxegol Oxalate25$12,765
Naloxone Hcl174$11,396
Gabapentin580$8,271
LinzessLinaclotide11$5,852
Diclofenac Sodium88$4,623
Methocarbamol263$3,520
Lidocaine40$3,211
Tizanidine Hcl181$2,706
Duloxetine Hcl125$2,300
Baclofen143$1,774
Topiramate26$1,694
Celecoxib59$1,626
Cyclobenzaprine Hcl205$1,525
Diclofenac Sodium ErDiclofenac Sodium14$1,031
Orphenadrine Citrate ErOrphenadrine Citrate21$560

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$24$5,85211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Melbourne

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →